NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to suspend trading in the three securities enumerated below (“Securities”) of Viveon Health Acquisition Corp. (the “Company”) from NYSE American. The staff suspended trading in the Company’s Securities because the Listings Qualifications Panel (the “Panel”) of the Committee for Review of the Board of Directors of the Exchange (the “Committee”) had issued a decision in which it upheld the Exchange’s previously announced determination to delist the Company’s Securities.

The Exchange previously announced on December 22, 2023 that it had commenced delisting proceedings with respect to the Company’s Securities that same day pursuant to Sections 119(b) and 119(f) of the NYSE American Company Guide because the Company failed to consummate a business combination (i) within 36 months of the effectiveness of its initial public offering registration statement, or (ii) such shorter period that the Company specified in its registration statement. The Company had the right to request a review of this delisting determination by the Panel.

The Company has a right to a review of the Panel’s decision to delist the Securities by the Committee by making a written request within 15 calendar days of the date of the Panel’s decision. The filing by the Exchange of an application with the Securities and Exchange Commission to delist the Securities is pending completion of all applicable procedures, including any appeal by the Company of the Panel’s decision.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240221845037/en/